M Araujo-Castro1, F Mariño-Sánchez2, A Acitores Cancela3, A García Fernández4, S García Duque5, V Rodríguez Berrocal3,5. 1. Neuroendocrinology Unit, Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal, Instituto de Investigación Biomédica Hospital Ramón Y Cajal (IRYCIS), Madrid, Spain. marta.araujo@salud.madrid.org. 2. Rhinology and Skull Base Surgery Unit, Otorhinolaryngology Department, Ramón y Cajal University Hospital, Madrid, Spain. 3. Pituitary Surgery Unit, Department of Neurosurgery, Hospital Universitario Ramón y Cajal, Madrid, Spain. 4. Rhinology and Skull Base Surgery Unit, Otorhinolaryngology Department, Hospital HM Puerta del Sur, Madrid, Spain. 5. Pituitary Surgery Unit, Department of Neurosurgery, Hospital Universitario Puerta del Sur, Madrid, Spain.
Abstract
PURPOSE: To identify presurgical and surgical factors associated with the development of diabetes insipidus (DI) after pituitary adenoma (PA) resection through an endoscopic endonasal transsphenoidal approach. METHODS: Data from 231 patients with functioning and non-functioning PAs who underwent an endoscopic endonasal transsphenoidal approach in the last ten years. RESULTS: 231 patients with 241 pituitary surgeries were included. Eighty-five percent harbored macroadenomas and 38.1% of them were invasive. After pituitary surgery, 12.5% (n = 30) developed transient DI and 5.0% (n = 12) permanent DI. The global risk of DI was higher in patients younger than 65 years (OR = 2.94, p = 0.029), with total tumoral resection (OR = 2.86, p = 0.007) and with diaphragm opening during pituitary resection (OR = 3.63, p = 0.0003). Once postoperative DI developed, the risk of permanent DI increased in those patients with larger PA (OR = 1.07 for each mm of craniocaudal diameter, p = 0.020), especially in those greater than 30 mm (OR = 8.33, p = 0.004). Moreover, diaphragm opening during pituitary resection (OR = 28.3, p = 0.018) predicted long-term DI independently of pituitary tumor size. The risk of permanent DI increased as PA craniocaudal diameter increased (r = 0.20, p = 0.002). CONCLUSION: In patients with PAs younger than 65 years, in whom diaphragm has been opened during pituitary surgery and/or with a total tumor resection, special hydric balance monitoring should be maintained in the postoperative period due to the increased risk of developing DI. The risk of permanent DI increases as PA craniocaudal diameter increased.
PURPOSE: To identify presurgical and surgical factors associated with the development of diabetes insipidus (DI) after pituitary adenoma (PA) resection through an endoscopic endonasal transsphenoidal approach. METHODS: Data from 231 patients with functioning and non-functioning PAs who underwent an endoscopic endonasal transsphenoidal approach in the last ten years. RESULTS: 231 patients with 241 pituitary surgeries were included. Eighty-five percent harbored macroadenomas and 38.1% of them were invasive. After pituitary surgery, 12.5% (n = 30) developed transient DI and 5.0% (n = 12) permanent DI. The global risk of DI was higher in patients younger than 65 years (OR = 2.94, p = 0.029), with total tumoral resection (OR = 2.86, p = 0.007) and with diaphragm opening during pituitary resection (OR = 3.63, p = 0.0003). Once postoperative DI developed, the risk of permanent DI increased in those patients with larger PA (OR = 1.07 for each mm of craniocaudal diameter, p = 0.020), especially in those greater than 30 mm (OR = 8.33, p = 0.004). Moreover, diaphragm opening during pituitary resection (OR = 28.3, p = 0.018) predicted long-term DI independently of pituitary tumor size. The risk of permanent DI increased as PA craniocaudal diameter increased (r = 0.20, p = 0.002). CONCLUSION: In patients with PAs younger than 65 years, in whom diaphragm has been opened during pituitary surgery and/or with a total tumor resection, special hydric balance monitoring should be maintained in the postoperative period due to the increased risk of developing DI. The risk of permanent DI increases as PA craniocaudal diameter increased.
Authors: Lynnette K Nieman; Beverly M K Biller; James W Findling; John Newell-Price; Martin O Savage; Paul M Stewart; Victor M Montori Journal: J Clin Endocrinol Metab Date: 2008-03-11 Impact factor: 5.958
Authors: Bettina Winzeler; Christian Zweifel; Nicole Nigro; Birsen Arici; Martina Bally; Philipp Schuetz; Claudine Angela Blum; Christopher Kelly; Sven Berkmann; Andreas Huber; Fred Gentili; Gelareh Zadeh; Hans Landolt; Luigi Mariani; Beat Müller; Mirjam Christ-Crain Journal: J Clin Endocrinol Metab Date: 2015-04-29 Impact factor: 5.958
Authors: Laurence Katznelson; Edward R Laws; Shlomo Melmed; Mark E Molitch; Mohammad Hassan Murad; Andrea Utz; John A H Wass Journal: J Clin Endocrinol Metab Date: 2014-10-30 Impact factor: 5.958
Authors: Matthew Schreckinger; Blake Walker; Jordan Knepper; Mark Hornyak; David Hong; Jung-Min Kim; Adam Folbe; Murali Guthikonda; Sandeep Mittal; Nicholas J Szerlip Journal: Pituitary Date: 2013-12 Impact factor: 4.107
Authors: M Araujo-Castro; E Pascual-Corrales; J S Martínez San Millan; G Rebolleda; H Pian; I Ruz-Caracuel; G De Los Santos Granados; L Ley Urzaiz; H F Escobar-Morreale; V Rodríguez Berrocal Journal: Endocrine Date: 2020-03-13 Impact factor: 3.633
Authors: Rafael Martinez-Perez; Michael W Kortz; William Florez-Perdomo; Timothy H Ung; A Samy Youssef Journal: Neurosurg Rev Date: 2022-02-12 Impact factor: 3.042
Authors: Juan Manuel Canelo Moreno; Elena Dios Fuentes; Eva Venegas Moreno; Pablo Jesús Remón Ruíz; Cristina Muñoz Gómez; Ana Piñar Gutiérrez; Eugenio Cárdenas Valdepeñas; Ariel Kaen; Alfonso Soto Moreno Journal: Front Endocrinol (Lausanne) Date: 2022-08-23 Impact factor: 6.055